Page last updated: 2024-11-01

nicardipine and Hyperoxia

nicardipine has been researched along with Hyperoxia in 1 studies

Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.

Hyperoxia: An abnormal increase in the amount of oxygen in the tissues and organs.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iizuka, N1
Nakahara, T1
Ushikubo, H1
Mori, A1
Sakamoto, K1
Ishii, K1

Other Studies

1 other study available for nicardipine and Hyperoxia

ArticleYear
Retinal region-dependent susceptibility of capillaries to high-concentration oxygen exposure and vascular endothelial growth factor receptor inhibition in neonatal mice.
    Journal of pharmacological sciences, 2015, Volume: 129, Issue:2

    Topics: Amlodipine; Animals; Animals, Newborn; Axitinib; Calcium Channel Blockers; Capillaries; Female; Hype

2015